Priority Date: 13.06.12 (US 201261659096P)

INTRANASAL DELIVERY OF CELL PERMEANT THERAPEUTICS FOR THE TREATMENT OF EDEMA

  • Application ID: EP13803979
  • Status: EXAMINATION REQUESTED

Attorney

no operation time available
Headquarter in Birmingham and 6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Barker Brettell LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 13.06.2012 - Priority Date (US 201261659096P)
  • 19.12.2013 - Publication A2 (WO2013188676)
  • 22.04.2015 - Publication A2 (EP2861243)

IPC Classification